Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk (original) (raw)
Kyle, R.A. & Rajkumar, S.V. Multiple myeloma. N. Engl. J. Med.351, 1860–1873 (2004). ArticleCAS Google Scholar
Palumbo, A. & Anderson, K. Multiple myeloma. N. Engl. J. Med.364, 1046–1060 (2011). ArticleCAS Google Scholar
Kyle, R.A. et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N. Engl. J. Med.346, 564–569 (2002). Article Google Scholar
Landgren, O. et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood114, 791–795 (2009). ArticleCAS Google Scholar
Altieri, A., Chen, B., Bermejo, J.L., Castro, F. & Hemminki, K. Familial risks and temporal incidence trends of multiple myeloma. Eur. J. Cancer42, 1661–1670 (2006). Article Google Scholar
Morgan, G.J. et al. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet376, 1989–1999 (2010). ArticleCAS Google Scholar
Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol.35, 34–41 (2006). Article Google Scholar
Schmermund, A. et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am. Heart J.144, 212–218 (2002). Article Google Scholar
Clayton, D.G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet.37, 1243–1246 (2005). ArticleCAS Google Scholar
Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet.38, 904–909 (2006). ArticleCAS Google Scholar
Pettiti, D. Meta-analysis Decision Analysis and Cost-Effectiveness Analysis (Oxford University Press, New York, USA, 1994).
Tomlinson, I.P. et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet.40, 623–630 (2008). ArticleCAS Google Scholar
Jung, C.H., Ro, S.H., Cao, J., Otto, N.M. & Kim, D.H. mTOR regulation of autophagy. FEBS Lett.584, 1287–1295 (2010). ArticleCAS Google Scholar
Liang, C. & Jung, J.U. Autophagy genes as tumor suppressors. Curr. Opin. Cell Biol.22, 226–233 (2010). ArticleCAS Google Scholar
Ocio, E.M., Mateos, M.V., Maiso, P., Pandiella, A. & San-Miguel, J.F. New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings. Lancet Oncol.9, 1157–1165 (2008). ArticleCAS Google Scholar
Taddesse-Heath, L., Meloni-Ehrig, A., Scheerle, J., Kelly, J.C. & Jaffe, E.S. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod. Pathol.23, 991–999 (2010). Article Google Scholar
Dib, A., Gabrea, A., Glebov, O.K., Bergsagel, P.L. & Kuehl, W.M. Characterization of MYC translocations in multiple myeloma cell lines. J. Natl. Cancer Inst. Monogr.39, 25–31 (2008). ArticleCAS Google Scholar
Huang, A. et al. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. Cancer Res.65, 5607–5619 (2005). ArticleCAS Google Scholar
Maertens, G.N., Cherepanov, P. & Engelman, A. Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin. J. Cell Sci.119, 2563–2571 (2006). ArticleCAS Google Scholar
Blake, D.J. et al. β-dystrobrevin, a member of the dystophin-related protein family. Proc. Natl. Acad. Sci. USA95, 241–246 (1998). ArticleCAS Google Scholar
Matys, V. et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res.34, D108–D110 (2006). ArticleCAS Google Scholar
Ferretti, V. et al. PReMod: a database of genome-wide mammalian _cis_-regulatory module predictions. Nucleic Acids Res.35, D122–D126 (2007). ArticleCAS Google Scholar
Walker, B.A. et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood108, 1733–1743 (2006). ArticleCAS Google Scholar
Stranger, B.E. et al. Genome-wide associations of gene expression variation in humans. PLoS Genet.1, e78 (2005). Article Google Scholar
Stranger, B.E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science315, 848–853 (2007). ArticleCAS Google Scholar
Fonseca, R. et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia23, 2210–2221 (2009). ArticleCAS Google Scholar
Dewald, G.W., Kyle, R.A., Hicks, G.A. & Greipp, P.R. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood66, 380–390 (1985). CASPubMed Google Scholar
Debes-Marun, C.S. et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia17, 427–436 (2003). ArticleCAS Google Scholar
Walker, B.A. et al. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood116, e56–e65 (2010). ArticleCAS Google Scholar
Landgren, O. & Weiss, B.M. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia23, 1691–1697 (2009). ArticleCAS Google Scholar
Enciso-Mora, V. et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat. Genet.42, 1126–1130 (2010). ArticleCAS Google Scholar
Crowther-Swanepoel, D. et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat. Genet.42, 132–136 (2010). ArticleCAS Google Scholar
Chiecchio, L. et al. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia20, 1610–1617 (2006). ArticleCAS Google Scholar
Neben, K. et al. Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica95, 1150–1157 (2010). ArticleCAS Google Scholar
Wuilleme, S. et al. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma. Leukemia19, 275–278 (2005). ArticleCAS Google Scholar
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet.81, 559–575 (2007). ArticleCAS Google Scholar
Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med.21, 1539–1558 (2002). Article Google Scholar
Ioannidis, J.P., Ntzani, E.E. & Trikalinos, T.A. 'Racial' differences in genetic effects for complex diseases. Nat. Genet.36, 1312–1318 (2004). ArticleCAS Google Scholar
Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics26, 2190–2191 (2010). ArticleCAS Google Scholar
Houlston, R.S. & Ford, D. Genetics of coeliac disease. QJM89, 737–743 (1996). ArticleCAS Google Scholar
Myers, S., Bottolo, L., Freeman, C., McVean, G. & Donnelly, P. A fine-scale map of recombination rates and hotspots across the human genome. Science310, 321–324 (2005). ArticleCAS Google Scholar
Gabriel, S.B. et al. The structure of haplotype blocks in the human genome. Science296, 2225–2229 (2002). ArticleCAS Google Scholar